NYU Abu Dhabi identifies NM1 protein as key regulator in genetic obesity
Updated
Updated · Daijiworld.com · May 9
NYU Abu Dhabi identifies NM1 protein as key regulator in genetic obesity
9 articles · Updated · Daijiworld.com · May 9
In mice, lead researcher Professor Piergiorgio Percipalle said faulty or missing NM1 caused oversized fat cells, lipid buildup around organs including the liver, and effects in both sexes regardless of diet.
The study linked the condition to inflammation, impaired mitochondrial energy production, insulin resistance and a pre-diabetic state, suggesting obesity can stem from disrupted gene control inside fat-cell nuclei.
Researchers are pursuing fat-tissue reprogramming therapies targeting underlying genetic mechanisms, though clinical use remains years away, while the findings challenge views of obesity as driven only by lifestyle or willpower.
This discovery suggests obesity can be genetic. Is it time to end the stigma and blame associated with body weight?
With new therapies aimed at reprogramming fat cells, are we on the verge of a genetic cure that could replace Ozempic?
If fat can be transformed into insulin-producing organs, what other secrets does our body hold for curing major diseases?
NM1 Discovery Redefines Obesity as a Genetic Disease, Opening Doors to Personalized Therapies
Overview
In 2026, researchers at NYU Abu Dhabi made a major breakthrough by discovering that Nuclear Myosin 1 (NM1) is a master regulator of gene expression in fat cells. Their study, published in Nature's Cell Death & Disease, revealed that NM1 is essential for healthy fat tissue development and function. By controlling which genes are turned on or off, NM1 influences the entire cellular machinery responsible for fat cell health and metabolism. This discovery marks a significant step forward in understanding the complex genetic mechanisms behind obesity and opens new possibilities for targeted therapies.